3 min read
Cleerly: October 18, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive evaluation of atherosclerotic plaque for guiding personalized treatment and tracking heart disease over time...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: September 19, 2022
Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.
7 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: August 1, 2022
The current approach to cardiovascular care is flawed for two reasons. One is the lack of a disease-based care paradigm with a focus on actual heart disease–atherosclerosis– in lieu of an emphasis on symptom-driven care that identifies only late-stage...
3 min read
Last week, our team at Cleerly had the opportunity to take part in a gathering of impassioned cardiac computed tomography (CT) leaders at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Las Vegas. As the former...
Cleerly: June 17, 2022
Cleerly Episode Featured on the AHA's Advancing Health Podcast Series
Dr. Leon D. Caldwell, Senior Director, Health Equity Strategies and Innovation, in the Institute of Diversity and Health Equity at the AHA, sits down with Dr. James Min, CEO and...
3 min read
Cleerly: June 8, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care, emphasizing comprehensive evaluation of atherosclerotic plaque and heart attack prevention, is changing the approach to heart health.
2 min read
Cleerly: May 19, 2022
For the last 50 years, cardiology care has focused on treating symptoms of heart disease, rather than its root cause - atherosclerosis. At Cleerly, we are transforming the approach to cardiovascular care with our precision health model that proactively...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: April 15, 2022
New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque - not secondary symptoms of heart disease.
4 min read
Cleerly is excited to have released our vision statement calling for a new approach to cardiovascular care. It's an important topic - not just for Cleerly, but for the healthcare industry and all the patients impacted by heart disease - and we're going...
4 min read
Cleerly is excited to have released our vision statement calling for a new approach to cardiovascular care. It's an important topic - not just for Cleerly, but for the healthcare industry and all the patients impacted by heart disease - and we're going...
